Key terms

About ABCL

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ABCL news

Today 1:52am ET Analysts Offer Insights on Healthcare Companies: Certara (CERT), Exact Sciences (EXAS) and AbCellera Biologics (ABCL) by TipRanks May 08 6:49am ET AbCellera price target lowered to $7 from $8 at KeyBanc by TipRanks May 07 4:33pm ET AbCellera reports Q1 EPS (14c), consensus (17c) by TipRanks May 07 4:33pm ET AbCellera Biologics Reviews Q1 Earnings with Corporate Presentation by TipRanks Apr 17 4:55am ET AbCellera management to meet with Truist by TipRanks Apr 15 7:50am ET AbCellera management to meet with Truist by TipRanks Mar 11 9:14am ET AbCellera gets upfront payment for collaboration with Biogen for antibodies by TipRanks Feb 24 10:11am ET Peter Thiel Retires from AbCellera Board, Dr. Andrew Lo Steps In by TipRanks Feb 23 7:33am ET Piper Sandler Reaffirms Their Buy Rating on AbCellera Biologics (ABCL) by TipRanks Feb 22 6:59am ET AbCellera upgraded to Buy at Benchmark after R&D progress by TipRanks Feb 22 6:17am ET AbCellera upgraded to Buy from Hold at Benchmark by TipRanks Feb 22 12:16am ET AbCellera Biologics: A Strong Buy on Robust Pipeline and Solid Financial Outlook by TipRanks Feb 21 8:23am ET AbCellera price target lowered to $17 from $21 at Stifel by TipRanks Feb 21 8:14am ET Stifel Nicolaus Reaffirms Their Buy Rating on AbCellera Biologics (ABCL) by TipRanks Feb 21 7:31am ET Analysts Offer Insights on Healthcare Companies: AbCellera Biologics (ABCL), Teladoc (TDOC) and Alnylam Pharma (ALNY) by TipRanks Feb 20 9:30pm ET Analysts Offer Insights on Healthcare Companies: Halozyme (HALO) and AbCellera Biologics (ABCL) by TipRanks Feb 20 4:47pm ET AbCellera Biologics Reviews 2023 Financial Performance by TipRanks Feb 20 4:07pm ET AbCellera reports FY23 EPS (51c), consensus (47c) by TipRanks

No recent press releases are available for ABCL

ABCL Financials

1-year income & revenue

Key terms

ABCL Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ABCL Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

NEW YORK, NEW YORK - MAY 03: Traders work on the floor of the New York Stock Exchange (NYSE) on May 03, 2024 in New York City. The Dow surged over 400 points in morning trading as new economic numbers showed that the central bank may cut interest rates sooner than expected. (Photo by Spencer Platt/Getty Images)
Spencer Platt/Getty Images North America/Getty Images
There’s a surprising bit of good news lurking in the stock market
Bruce Garelick was found guilty of insider trading
John Minchillo/AP
Investor found guilty in Trump Media insider trading case
People walk toward an entrance to Disneyland in Anaheim, California on April 24, 2023.
Mario Tama/Getty Images/File
Americans are shopping less but they’re still spending on flights, hotels and Disneyland
Scaffolding and construction netting near an apartment building in New York, US, on Wednesday, Oct. 11, 2023. Monthly fees and expenses for inspections, insurance and climate-friendly upgrades are squeezing residents of the city's many co-op and condo buildings. Photographer: Michael Nagle/Bloomberg
Michael Nagle/Bloomberg/Getty Images
For US renters, the chance of owning a home is going from bad to worse